In their own responses to the senators’ inquiries last fall, both Pfizer and Lilly emphasized the independence of their ...

Economists around the world expect muted U.S. economic growth in the coming quarters, and some indicators have shown an increased likelihood of a 2025 recession in recent weeks. [ Sign up for ...

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...

Recent developments at Eli Lilly (NYSE:LLY) have highlighted significant strides in both product innovation and operational ...

Most medical devices in the United States come to market with limited clinical data, and device surveillance is viewed as a ...

GLP-1 receptor agonists (GLP-1RAs) were initially approved for diabetes treatment (e.g., Ozempic®) but have revolutionized weight management ...

The Maryland Senate voted to allow a state board to extend its mandate for lowering prescription drug costs to all residents.

U.S. equities were mixed at midday as the markets weighed a better-than-expected report on inflation and more tariff news.

Analysts, who are highly bullish on the stock, have fretted for some time that Viking needed a partner to actually make the product, assuming it gains regulatory approval. Viking ...

WASHINGTON, D.C. U.S. Senate Democratic Whip Dick Durbin (D-IL) sent letters to five telehealth companies that have held ...

President Donald Trump's nominee to lead the agency overseeing Medicare should divest financial ties to healthcare and ...